Cruciate Ligament Diagnosis & Treatment Market Size was valued at USD 5.83 Billion in 2023. The Global Cruciate Ligament Diagnosis & Treatment industry is projected to grow from USD 6.32 Billion in 2024 to USD 9.63 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.82% during the forecast period (2024 - 2032).
Numerous other factors such as growing number of knee reconstruction surgeries, increase in aging population coupled with rising incidences of diseases related to age such as rheumatoid arthritis and osteoarthritis, and increasing government assistance are continuously contributing to the growth of the cruciate ligament diagnosis and treatment market.
Despite these drivers, there are some issues associated with the cruciate ligament diagnosis and treatment market. The complications associated with the treatment, lack of skilled or trained physicians, and poor healthcare system in low and middle-income countries may hamper the growth of the market.
The cruciate ligaments are a pair of ligaments in the knee that link the tibia to the femur via a crisscross pattern. The market is expanding rapidly because of the increased incidence of knee injuries among athletes and the rising preference for less intrusive treatment options.
One of the most often injured joints is the knee, especially in physically active people like sportsmen. Increasing numbers of knee operations are being done worldwide as a direct result of the rising incidence of sports-related injuries among athletes. The rising incidence of knee injuries necessitating surgical repair of the cruciate ligament is a key factor driving the market's expansion. There are two cruciate ligaments in the knee, one in the front and one in the rear.
The market for cruciate ligament diagnosis and treatment has expanded as the number of individuals engaging in sports has increased. Injuries to the posterior cruciate ligament prevent full extension of the affected athlete's leg, frequently necessitating reconstructive surgery. The prevalence of age-related disorders including osteoarthritis and rheumatoid arthritis is on the rise, which in turn contributes to the expansion of the cruciate ligament diagnosis and treatment market.
News:
The Bridge Registry Post-Market Study of the company's Bridge-Enhanced ACL Restoration (BEAR®) Implant for anterior cruciate ligament (ACL) tears will begin in May 2023, according to Miach Orthopaedics, Inc., a privately held company focused on developing bio-engineered surgical implants for connective tissue restoration. Up to 750 patients at up to 30 sites in the United States will be enrolled in the Bridge Registry (NCT05398341) to evaluate real-world evidence of the BEAR Implant. At two years, we will test knee function and feeling using the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation, and at one year, we will quantify knee laxity using the Lachman scoring system.
Research Methodology
Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, treatment assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.
The extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the cruciate ligament diagnosis and treatment market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and treatment perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.
The cruciate ligament diagnosis and treatment market is segmented on the basis of type, injury type, product, diagnosis, treatment, and end-user.
Based on type, the cruciate ligament diagnosis and treatment market is classified as Posterior Cruciate Ligament (PCL) and Anterior Cruciate Ligament (ACL).
The segments for injury type for the cruciate ligament diagnosis and treatment market are classified as grade I, grade II, and grade III.
On the basis of product, the cruciate ligament diagnosis and treatment market is classified as cemented implants, cement-less implants, partial implants, and revision implants.
Based on indication, the cruciate ligament diagnosis and treatment market is classified as osteoarthritis, rheumatoid arthritis, trauma, and others.
The diagnosis segment for the cruciate ligament diagnosis and treatment market is classified as imaging others. The imaging segment is further classified as Magnetic Resonance Imaging (MRI), ultrasound, laparoscopy, and others.
Based on treatment, the cruciate ligament diagnosis and treatment market is classified as surgery, therapies, devices, and others. Surgery can be further sub-divided into arthroscopy, Anterior Cruciate Ligament (ACL) reconstruction, and others. The therapies include rehabilitation and physical therapies. The devices include elastic bandages and others.
On the basis of end-user, the cruciate ligament diagnosis and treatment market is classified as hospitals, orthopedic clinics, Ambulatory Surgical Centers (ASC), and others.
Geographically, the global market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.
The European market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the Rest of Western Europe.
The Asia Pacific market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia Pacific.
The Middle Eastern and African market is segmented into the Middle East and Africa.
May 2023, Saw the launch of ACLTear.com, a patient-focused website created by Arthrex, a world leader in minimally invasive orthopedic technology. The site provides information on anterior cruciate ligament (ACL) injuries, the advantages of knee preservation technology, and resources for patients to find surgeons in their area who are skilled in minimally invasive ACL reconstruction. Arthrex, the undisputed leader in surgical innovation, is shaping the way ACL tears will be treated in the years to come. If you or someone you know is in need of in-depth knowledge based on substantial orthopedic research and actual patient experiences, ACLTear.com is an excellent educational resource.
Regional Market Summary
Cruciate Ligament Diagnosis & Treatment Market, by Region Market Share, 2017 (%)
Source: MRFR Analysis
The Americas dominates the cruciate ligament diagnosis and treatment market owing to the rising prevalence of osteoarthritis among the elderly population, well-developed surgical technology, high healthcare expenditure, and the presence of the leading players.
This market is attracting many key participants such as Stryker Corporation; Zimmer Biomet; DePuySynthes, Inc., Arthrex, Inc.; Smith & Nephew plc; and CONMED Corporation. For instance, Smith & Nephew acquired the diversified product portfolio for orthopedic soft tissue repair from ArthroCare Corporation further strengthening the position of the company in the global market.
Europe holds the second position in the cruciate ligament diagnosis and treatment market. It is expected that the rising contribution towards research and development for the development of surgical implants and increasing competition among marketers for drug launch are likely to drive the European cruciate ligament diagnosis and treatment market. For instance, in May 2017 Ablynx, a biopharmaceutical company headquartered in Belgium, announced the completion of a preclinical package for a novel nanobody, ALX-1141 for the treatment of osteoarthritis. Merck will now be responsible for the further clinical development of the molecule.
Asia Pacific is the fastest growing cruciate ligament diagnosis and treatment market owing to a huge patient pool, increasing demand for treatments, and rising healthcare expenditure. For instance, in July 2017, Kolon Pharmaceutical got the approval for the World's first cell and gene therapy for knee osteoarthritis in Korea. Thus, all these factors are cumulatively responsible for the growth in this region.
The Middle East and Africa holds the lowest share of the global cruciate ligament diagnosis and treatment market due to low development, lack of technical knowledge, and poor medical facilities.
Key Players
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â USD 9.63 Billion |
| Â Â CAGR | Â Â 9.82% |
| Â Â Base Year | Â Â 2023 |
| Â Â Forecast Period | Â Â 2024-2032 |
| Â Â Historical Data | Â Â 2022 |
| Â Â Forecast Units | Â Â Value (USD Billion) |
| Â Â Report Coverage | Â Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â Type, Injury type, Product, Diagnosis, Treatment, and End-user |
| Â Â Geographies Covered | Â Â North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
|   Key Vendors |   Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet (U.S.), DePuy Synthes, Inc. (U.S.), CONMED Corporation (U.S.), Smith & Nephew plc. (U.S.), DJO Global Inc. (U.S.), Breg, Inc. (U.S.), Bauerfeind AG (Germany), Össur hf. (Iceland), BSN Medical GmbH (Germany), 3M Company (U.S.), Otto Bock Healthcare GmbH (Germany), THUASNE SA (France), medi GmbH & Co. KG (Germany), DeRoyal Industries Inc. (U.S.), Corin Group (UK), United Orthopedic Corporation (Taiwan), Exactech Inc. (U.S.), Japan Medical Dynamic Marketing (Japan), Tornier Inc. (U.S.), and others |
| Â Â Key Market Opportunities | Â Â New product launches and R&D Amongst major key Players |
|   Key Market Drivers |  Growing number of knee reconstruction surgeries · Increase in aging population · Rising incidences of diseases · Increasing Government assistance |
Frequently Asked Questions (FAQ) :
Major products used in cruciate ligament diagnosis and treatment include cemented implants, cement-less implants, partial implants, and revision implants.
Global cruciate ligament diagnosis and treatment market is expected to exhibit a strong 9.82% CAGR over the forecast period from 2024 to 2032.
The growing prevalence of sports-related cruciate ligament injuries is the major driver for the cruciate ligament diagnosis and treatment market.
The Americas dominate the global cruciate ligament diagnosis and treatment market.
Leading players in the cruciate ligament diagnosis and treatment market include Breg Inc., Stryker, and Arthrex, among others.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
